Chondrosarcoma clinical trials
The registry lists 77 studies for Chondrosarcoma across more than 10 countries. 20 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-21.
Status
- Completed
- 38
- Recruiting
- 16
- Active, not recruiting
- 9
- Terminated
- 4
- Status unknown
- 3
- Not yet recruiting
- 2
Phase
- Phase 2
- 35
- Phase 1
- 16
- Phase 3
- 2
- Phase 4
- 1
- Early Phase 1
- 1
Where
- United States
- 44
- France
- 13
- Italy
- 7
- Australia
- 7
- Spain
- 7
- Netherlands
- 5
Who runs them
National Cancer Institute (NCI) (7) · Istituto Ortopedico Rizzoli (5) · Sarcoma Alliance for Research through Collaboration (3) · SWOG Cancer Research Network (3) · Salarius Pharmaceuticals, LLC (2) · Memorial Sloan Kettering Cancer Center (2) · Infinity Pharmaceuticals, Inc. (2) · Centre Leon Berard (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 77 — search for more.
- Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base TumorsRecruitingNCT06176989Phase 21 country
- Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway AlterationRecruitingNCT04040205Phase 21 country
- Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic SequencingRecruitingNCT067493661 country
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsRecruitingNCT05039801Phase 11 country
- Assessment of Healing and Function After Reconstruction Surgery for Bone SarcomasRecruitingNCT034424651 country
- Clinical Applicability of Liquid Biopsy in ChondrosarcomaNot yet recruitingNCT074928231 country
- Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the BoneRecruitingNCT050332881 country
- BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of BreastAvailableNCT040912951 country
- Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone SarcomasRecruitingNCT04055220Not applicable1 country
- A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative PlanningRecruitingNCT06387485Not applicable1 country
- Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage SurgeryRecruitingNCT057796701 country
- Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull BaseRecruitingNCT05861245Not applicable1 country
- Diagnostic and Therapeutic Targets in Cartilaginous TumoursRecruitingNCT073155421 country
- PET-imaging of Two Vartumabs in Patients With Solid TumorsRecruitingNCT06645808Early Phase 11 country
- Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton TherapyRecruitingNCT06029218Not applicable1 country
- Image Assisted Optimization of Proton Radiation Therapy in Chordomas and ChondrosarcomasRecruitingNCT048326201 country
- A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)Enrolling by invitationNCT05266196Phase 1/21 country
- A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade ChondrosarcomaRecruitingNCT05193188Phase 21 country
- Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone SarcomasNot yet recruitingNCT05515068
- Neutrophils in Bone SarcomasRecruitingNCT048674211 country
- Vismodegib in Treating Patients With Advanced ChondrosarcomasActive, not recruitingNCT01267955Phase 21 country
- Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsActive, not recruitingNCT04521686Phase 19 countries
- A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone SarcomasCompletedNCT02389244Phase 21 country
- Tazemetostat Expanded Access Program for Adults With Solid TumorsNo longer availableNCT03874455
- A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid TumorsActive, not recruitingNCT04673942Phase 21 country
- Long-Term Longitudinal QoL in Patients Undergoing EEAActive, not recruitingNCT040879021 country
- AG-120 in People With IDH1 Mutant ChondrosarcomaActive, not recruitingNCT04278781Phase 21 country
- Proton Beam Therapy for ChondrosarcomaActive, not recruitingNCT00496522Phase 21 country
- Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 MutationCompletedNCT02073994Phase 12 countries
- Clear Cell Chondrosarcoma in ItalyActive, not recruitingNCT07360964Not applicable1 country
- Proton Radiation for Chordomas and ChondrosarcomasCompletedNCT01449149Not applicable1 country
- Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b TrialActive, not recruitingNCT03173976Phase 11 country
- Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILECompletedNCT065359971 country
- Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersTerminatedNCT04553692Phase 15 countries
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT040284791 country
- Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs ResectionCompletedNCT067147731 country
- Itacitinib in Treating Patients With Refractory Metastatic/Advanced SarcomasTerminatedNCT03670069Phase 11 country
- Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRICompletedNCT01336803Phase 21 country
- Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related SarcomasActive, not recruitingNCT03600649Phase 11 country
- A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 MutationCompletedNCT03684811Phase 1/26 countries
- SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma SubtypesCompletedNCT02048371Phase 21 country
- Imatinib in Patients With Desmoid Tumor and ChondrosarcomaCompletedNCT00928525Phase 21 country
- Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid ChondrosarcomaCompletedNCT02066285Phase 21 country
- Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic ChondrosarcomaCompletedNCT01330966Phase 22 countries
- A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)TerminatedNCT00543712Phase 22 countries
- Periosteal Chondrosarcoma: a Single Institution ExperienceCompletedNCT055118831 country
- Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue SarcomaCompletedNCT00346164Phase 35 countries
- Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and ChondrosarcomaCompletedNCT02821507Phase 22 countries
- Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue SarcomaCompletedNCT01532687Phase 21 country
- Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 MutationCompletedNCT02273739Phase 1/22 countries